Cell Signaling Technology

Phospho-Tuberin/TSC2 (Ser939) Antibody

#3615 · western blot · $148,362

100
Citing papers
11.5k
Combined citations
Supplier page Find this product

Research areas

Fibroblast Growth Factor Research9Genomics, phytochemicals, and oxidative stress8Hippo pathway signaling and YAP/TAZ7PI3K/AKT/mTOR signaling in cancer5Epigenetics and DNA Methylation5Ubiquitin and proteasome pathways5Acute Myeloid Leukemia Research4Adipose Tissue and Metabolism4

Papers citing this product

1
Research Resource: Comprehensive Expression Atlas of the Fibroblast Growth Factor System in Adult Mouse
Molecular Endocrinology·2010·679 cit.·DOI
2
Dynamin-Related Protein 1–Mediated Mitochondrial Mitotic Fission Permits Hyperproliferation of Vascular Smooth Muscle Cells and Offers a Novel Therapeutic Target in Pulmonary Hypertension
Circulation Research·2012·457 cit.·DOI
3
The <i>C. elegans</i> p38 MAPK pathway regulates nuclear localization of the transcription factor SKN-1 in oxidative stress response
Genes & Development·2005·451 cit.·DOI
4
Evidence of Placental Translation Inhibition and Endoplasmic Reticulum Stress in the Etiology of Human Intrauterine Growth Restriction
American Journal Of Pathology·2008·386 cit.·DOI
5
A Comparison of Azacitidine and Decitabine Activities in Acute Myeloid Leukemia Cell Lines
PLoS ONE·2010·357 cit.·DOI
6
Microbiome-Derived Tryptophan Metabolites and Their Aryl Hydrocarbon Receptor-Dependent Agonist and Antagonist Activities
Molecular Pharmacology·2014·337 cit.·DOI
7
MicroRNA-155 Modulates Treg and Th17 Cells Differentiation and Th17 Cell Function by Targeting SOCS1
PLoS ONE·2012·309 cit.·DOI
8
Mechanism of action of isothiocyanates: the induction of ARE-regulated genes is associated with activation of ERK and JNK and the phosphorylation and nuclear translocation of Nrf2
Molecular Cancer Therapeutics·2006·263 cit.·DOI
9
Gilteritinib, a FLT3/AXL inhibitor, shows antileukemic activity in mouse models of FLT3 mutated acute myeloid leukemia
Investigational New Drugs·2017·254 cit.·DOI
10
Downregulation of Blood-Brain Barrier Phenotype by Proinflammatory Cytokines Involves NADPH Oxidase-Dependent ROS Generation: Consequences for Interendothelial Adherens and Tight Junctions
PLoS ONE·2014·253 cit.·DOI

Similar products

ProductVendorEvidencePricePapers
Phospho-Tuberin/TSC2 (Ser939) AntibodyrabbitCell Signaling Technology———

Rate this reagent

Used this in your lab? Leave a quick rating. Reviews are anonymous and verified by academic email before they appear.

Your email is never shown publicly.